US stocks move: Corteva plummets on November 12 - Q3 results miss expectations, weak Brazilian market, full-year guidance lowered, and restructuring costs

Corteva November 12: Analysis of Major Decline

Keywords: Q3 earnings miss, weak Brazilian market, full-year guidance cut, restructuring charges

1. On November 12, Corteva released its results for the third quarter of 2026. Adjusted earnings per share from continuing operations were only $0.06, down 57% year-on-year and well below the analyst expectation of $0.10. Net sales were $1.59 billion, down 9% year-on-year and short of the market consensus of $1.77 billion.

2. In the third quarter, organic sales in Latin America declined by 31%, with the crop protection market in Brazil weakening. The CEO stated that the Brazilian market performed "significantly weaker than expected."

3. The company lowered its adjusted full-year 2026 operating earnings per share guidance to $0.76–$0.80 and adjusted EBITDA guidance to $1.1 billion–$1.125 billion, reflecting ongoing pressures in the Brazilian market.

4. The company plans to book net pre-tax restructuring charges of about $130 million to $140 million in 2026 to optimize its crop protection manufacturing network.

(Disclaimer: This content is generated by AI technology from publicly available information for reference only and does not constitute investment advice.)